Search

everythinglearnresearchcommunity

for

Search:↓

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Rituximab can cause skin issues, but baricitinib may help improve them.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Brain fog in lupus is common, worrying, and often not treated properly.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Older men with late-onset lupus have a higher mortality rate than women.

Researchers found a new mutation in the LIPH gene of a woman with a rare hair condition.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

People with Lichen Planus have thicker carotid artery walls, but it's not solely due to Lichen Planus when other factors are considered.

Most cases were lichen planus pigmentosus, highlighting the need for accurate diagnosis for proper treatment.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Treatment improved some symptoms but not all.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

PRP injections for hair loss may cause scalp nodules that can persist but often regress on their own.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

The study found no significant link between the symptoms, tissue analysis, and immunofluorescence results in scarring hair loss conditions.